Correlation Between Viatris and Adverum Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Viatris and Adverum Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Adverum Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viatris and Adverum Biotechnologies, you can compare the effects of market volatilities on Viatris and Adverum Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Adverum Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Adverum Biotechnologies.

Diversification Opportunities for Viatris and Adverum Biotechnologies

-0.18

Correlation Coefficient

Viatris  Adverum Biotechnologies

Good diversification

The 3 months correlation between Viatris and Adverum is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Adverum Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adverum Biotechnologies and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Adverum Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adverum Biotechnologies has no effect on the direction of Viatris i.e., Viatris and Adverum Biotechnologies go up and down completely randomly.

Pair Corralation between Viatris and Adverum Biotechnologies

Given the investment horizon of 90 days Viatris is expected to under-perform the Adverum Biotechnologies. But the stock apears to be less risky and, when comparing its historical volatility, Viatris is 2.08 times less risky than Adverum Biotechnologies. The stock trades about -0.22 of its potential returns per unit of risk. The Adverum Biotechnologies is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  469.00  in Adverum Biotechnologies on December 29, 2024 and sell it today you would lose (8.00) from holding Adverum Biotechnologies or give up 1.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Viatris  vs.  Adverum Biotechnologies

Viatris

Risk-Adjusted Performance

Very Weak

Over the last 90 days Viatris has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Adverum Biotechnologies

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Adverum Biotechnologies are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Adverum Biotechnologies is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Viatris and Adverum Biotechnologies

The main advantage of trading using opposite Viatris and Adverum Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Adverum Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will offset losses from the drop in Adverum Biotechnologies' long position.

The idea behind Viatris and Adverum Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.